58727001: Phencyclidine dependence (disorder)

• SNOMED CT Concept\Clinical finding (finding)\...
• \Mental state, behavior and/or psychosocial function finding (finding)\Behavior finding\Health-related behavior finding\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\...
• \The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Psychoactive substance dependence\Hallucinogen dependence\PCP dependence
• \Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterized by the pattern and consequences of hallucinogen use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterised by the pattern and consequences of phencyclidine use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\PCP dependence
• \Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterized by the pattern and consequences of hallucinogen use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Hallucinogen dependence\PCP dependence
• \Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Hallucinogen dependence\PCP dependence
• \Disease\Disorder caused by psychoactive substance\Phencyclidine-related disorder\Disorder characterised by the pattern and consequences of phencyclidine use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\PCP dependence
• \Disease\Disorder caused by psychoactive substance\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterized by the pattern and consequences of hallucinogen use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterised by the pattern and consequences of phencyclidine use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\PCP dependence
• \Disease\Disorder caused by psychoactive substance\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterized by the pattern and consequences of hallucinogen use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Hallucinogen dependence\PCP dependence
• \Disease\Disorder caused by psychoactive substance\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Hallucinogen dependence\PCP dependence
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Psychoactive substance dependence\Hallucinogen dependence\PCP dependence
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterized by the pattern and consequences of hallucinogen use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterised by the pattern and consequences of phencyclidine use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\PCP dependence
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Disorder characterized by the pattern and consequences of hallucinogen use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Hallucinogen dependence\PCP dependence
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Hallucinogen dependence\PCP dependence

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
97584017	PCP dependence	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
97585016	Phencyclidine dependence	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2620917015	Phencyclidine (PCP) dependence	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2913549011	Phencyclidine dependence (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4582111000241114	dépendance à la phencyclidine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Reference Sets

GB English

US English

Back to Start